pSivida
 | This article needs additional citations for verification. (March 2020) |
| Company type | Public company |
|---|---|
| Nasdaq: PSDV ASX: PVA FWB: PV3 | |
| Industry | Pharmaceuticals |
| Headquarters | , |
Number of locations | 2 |
| Products | Iluvien |
| Website | www |
EyePoint Pharmaceuticals, Inc. (formerly pSivida Corp.) pSivida is a Watertown, Massachusetts company specialising in the application of microelectromechanical systems (MEMS) and nanotechnology to drug delivery.
pSivida obtained porous silicon technology from the British government Defence Evaluation and Research Agency (DERA, now QinetiQ).[citation needed] QinetiQ continues to be a strategic partner.[citation needed].In April 2018, pSivida purchased eye products firm Icon Bioscience.[1]
See also
- Alimera Sciences, pSvida's partner on Iluvien
References
- ^ Letter, The Pharma. "BRIEF—pSivida to buy eye products firm Icon Bioscience". www.thepharmaletter.com. Retrieved 2018-06-22.
External links
- Official website
- "pSivida (PSDV) Enters Two Funded Evaluation Agreements with Leading Pharma". StreetInsider.com. May 12, 2015. Retrieved May 15, 2015.
- Lindon, Hal (May 5, 2014). "UPDATE: pSivida Issues Presentation of Preclinical Data Showing Sustained Release of Avastin Using Tethadur". Benzinga. Retrieved May 15, 2015.
pSivida's Dinesh K. Nadarassan presented a poster entitled "Sustained Release of Bevacizumab (Avastin) from BioSilicon"
- pSivida Mesoporous silicon patent
| Divisions and subsidiaries |
| ||||
|---|---|---|---|---|---|
| Shareholdings and partnerships | |||||
| Products | |||||
| Places and vessels | |||||
| Predecessors | |||||
| People | |||||
 | This United States manufacturing company–related article is a stub. You can help Wikipedia by expanding it. |
 | This article about a medical, pharmaceutical or biotechnological corporation or company is a stub. You can help Wikipedia by expanding it. |